Global EditionASIA 中文双语Français
World

Vaccine may come before US election, report says

By ANDREW COHEN in New York | China Daily | Updated: 2020-09-04 00:00
Share
Share - WeChat

The US Centers for Disease Control and Prevention, or CDC, has alerted state and local public health officials nationwide to prepare to distribute a novel coronavirus vaccine to healthcare workers and other high-risk groups as early as late October, a media report said.

The notifications were sent out last week, the same day US President Donald Trump told the nation in his speech to the Republican National Convention that a coronavirus vaccine may arrive before the end of the year.

In recent days, Anthony Fauci, the government's top infectious diseases expert, and Stephen Hahn, the head of the US Food and Drug Administration, have said that a vaccine could be available for certain groups before clinical trials have been completed-if the data were overwhelmingly positive.

The possibility of a vaccine by the Nov 3 election raises concerns that the Trump administration is trying to rush the process for political gain.

"This timeline of the initial deployment at the end of October is deeply worrisome for the politicization of public health and the potential safety ramifications,"Saskia Popescu, an infection prevention epidemiologist in Arizona, told The New York Times."It's hard not to see this as a push for a preelection vaccine."

The CDC notice cautioned its plans were still hypothetical and that "the COVID-19 vaccine landscape is evolving and uncertain, and these scenarios may evolve as more information is available".

Fauci told MSNBC that, based on the patient enrollment rate in vaccine trials now underway, there could be enough clinical data to know by November or December that one of the vaccines is safe and effective. "Is it conceivable that you could get an answer before then? Yes, it's conceivable."

Unnamed candidates

The CDC notifications outlined plans for distributing two unnamed vaccine candidates-each requiring two doses a few weeks apart-to healthcare professionals, including nursing home employees, along with other essential workers, including national security personnel.

The documents also mention prioritizing vaccinations for other high-risk groups, including those over 65, prison populations, Native Americans and "racial and ethnic minority populations", the Times reported.

Iowa State University on Wednesday reversed a decision to allow 25,000 fans into its football season opener against the University of Louisiana-Lafayette on Sept 12 and now will play in an empty stadium.

On the drug front, other potential good news came on Wednesday from the World Health Organization with reports that corticosteroid drugs could reduce the risk of death by 20 percent in critically ill COVID-19 patients.

The WHO's clinical care lead, Janet Diaz, said the agency had updated its advice to include a "strong recommendation" for the use of steroids in patients with severe and critical COVID-19.

The findings, published in the Journal of the American Medical Association, reinforced results announced in June, when the steroid dexamethasone became the first drug shown to be able to reduce death rates among severely sick COVID-19 patients.

The WHO's updated guidance, published on its website on Wednesday, said corticosteroids should only be used in treatment of the sickest patients, and not in nonsevere cases, because "the treatment brought no benefits (in milder cases) and could even prove harmful".

Ai Heping in New York and agencies contributed to this story.

 

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US